(Q48632169)

13 February 2018

title

Misonidazole combined with hyperfractionation in the management of malignant glioma (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

2 August 2023

author name string

D. S. Fulton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

R. C. Urtasun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

K. H. Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

P. H. Geggie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

H. Thomas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

P. J. Muller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

J. Moody

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

H. Tanasichuk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

B. Mielke

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

E. Johnson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090367

2 August 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0360301684905339?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

https://api.elsevier.com/content/article/PII:0360301684905339?httpAccept=text/plain

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

International Journal of Radiation Oncology Biology Physics

2 August 2023

published in

1 reference

13 February 2018

volume

10

1 reference

13 February 2018

issue

9

1 reference

13 February 2018

page(s)

1709-1712

1 reference

13 February 2018

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Superfractionation: its rationale and anticipated benefits.

2 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Super fractionation in glioblastoma multiforme-results of a phase II study

2 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Prognostic factors for patients with brain tumors

2 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Assumptions in the radiotherapy of glioblastoma

2 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

2 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

2 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

2 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

2 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

2 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

2 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

2 August 2023

Hyperfractionation

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90533-9

2 August 2023

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018